Search
Search Results
-
Willingness to pay for haemodialysis among patients with chronic kidney disease in Abuja, Nigeria
BackgroundEvidence of willingness to pay for kidney replacement therapy is scarce in low-middle-income countries, including Nigeria’s Formal Sector...
-
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening
IntroductionThis study investigates Iranian men’s willingness to pay (WTP) for prostate cancer (PCa) screening and influencing factor, along with the...
-
Monetary valuation of COVID-19 informal care: caregivers’ willingness to pay and willingness to accept
BackgroundInformal care can reduce hospitalization frequency and time, elevate bed turnover, and increase the health systems' capacity. This type of...
-
Financing COVID-19 vaccination in sub-Saharan Africa: lessons from a nation-wide willingness to pay (WTP) survey in Ghana
BackgroundOver 13 million doses of the corona virus disease, 2019 (COVID-19) vaccines have been administered in Ghana as at March, 2022; 28.5% of the...
-
Willingness to pay for chronic disease management services provided by primary care nurses
BackgroundDue to the rapid increase in chronic diseases in South Korea, the Korean government has expanded chronic disease management to primary...
-
Prediction of COVID-19 patients’ participation in financing informal care using machine learning methods: willingness to pay and willingness to accept approaches
BackgroundInformal care plays an essential role in managing the COVID-19 pandemic. Expanding health insurance packages that reimburse caregivers'...
-
Sociodemographic determinants of vaccination and willingness to pay for COVID-19 vaccines in Hungary, results of a cross-sectional online questionnaire
BackgroundSeveral different coronavirus disease (COVID-19) vaccines were authorized and distributed all over the world, including Hungary, but...
-
Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel
BackgroundmRNA technology is currently being investigated for a range of oncology indications. We assessed the willingness to pay (WTP) of the...
-
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?
ObjectivesThe German Pharmaceutical Market Restructuring Act (AMNOG, 2011) is a two-stage process to regulate the price of new pharmaceuticals in...
-
Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China
The objective of this study was to estimate the willingness to pay (WTP) per quality-adjusted life year (QALY) among people with malignancies in...
-
Health utilities and willingness to pay in adult patients with coeliac disease in Hungary
BackgroundCoeliac disease (CD) is a life-long food-related disorder with a global prevalence of approximately 1%. Patients with CD often experience...
-
Should Commercial Diagnostic Testing Be Stimulated or Discouraged? Analyzing Willingness-to-Pay and Market Externalities of Three Commercial Diagnostic Tests in The Netherlands
IntroductionConsumers may purchase commercial diagnostic tests (CDT) without prior doctor consultation. This paper analyzes three CDT...
-
Caretakers’ stated willingness to pay for children’s spectacles in cross river state, Nigeria and its implication for a cross-subsidisation scheme: a cross-sectional study
BackgroundUnderstanding caretakers’ willingness to pay (WTP) for their children’s spectacles is essential to improving the sustainability of...
-
Determinants of willingness to pay for community-based health insurance scheme among households in rural community of southern Ethiopia
BackgroundCommunity-based health insurance programs are being acknowledged as effective strategies to attain universal health coverage and mitigate...
-
Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks
Recently, due to the corona virus outbreak, pandemics and their effects have been at the forefront of the research agenda. However, estimates of the...
-
Preferences and Willingness to Pay for Medication in Patients with Renal Cell Carcinoma in China: A Discrete-Choice Experiment
ObjectiveWe aimed to assess the relative importance of attributes and the willingness to pay for pharmacological therapies among patients with renal...
-
Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment
Lost productivity is one of the largest costs associated with foodborne illness (FBI); however, the methods used to estimate lost productivity are...
-
Willingness to pay for HPV vaccine among female health care workers in a Chinese nationwide survey
BackgroundPayment methods for human papillomavirus (HPV) vaccine could substantially influence vaccination behavior. In China, HPV vaccination uptake...
-
QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment
PurposeQuality-adjusted life-year (QALY) is a dominant measurement of health gain in economic evaluations for pricing drugs. However, end-of-life...
-
Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
PurposeTo quantify the preferences for an oral antidiabetic drug (OAD) among patients with type 2 diabetes mellitus (T2DM) in China.
Methods ...